Literature DB >> 17438332

Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis.

Gordon P Meares1, Richard S Jope.   

Abstract

Mechanisms regulating the nuclear localization of glycogen synthase kinase-3beta (GSK3beta) remained enigmatic despite the crucial regulation by nuclear GSK3beta of important cellular functions. These include regulation of gene expression, cell cycle progression, and apoptosis, achieved by the phosphorylation by GSK3 of nuclear substrates (e.g. numerous transcription factors). We resolved this mechanism by identifying a bipartite nuclear localization sequence (NLS) that is necessary for the nuclear accumulation of GSK3beta and is sufficient to drive yellow fluorescent protein into the nucleus. Despite the NLS, most GSK3beta is cytosolic, sequestered in protein complexes that, although still mobile in the cytosol, block the NLS. Conditions promoting nuclear translocation of GSK3beta release it from cytosolic complexes, allowing the NLS to direct nuclear import. Using this information to prepare a nucleus-excluded active GSK3 construct, we found that the antiapoptotic effect of GSK3beta in tumor necrosis factor-induced apoptosis is mediated by cytosolic, not nuclear, GSK3beta. Identification of a GSK3beta NLS allows new strategies to decipher and manipulate its subcellular actions regulating gene expression and apoptosis and its involvement in diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438332      PMCID: PMC1948884          DOI: 10.1074/jbc.M700610200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

Authors:  S Frame; P Cohen; R M Biondi
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

Review 2.  Studying protein dynamics in living cells.

Authors:  J Lippincott-Schwartz; E Snapp; A Kenworthy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

3.  Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

Authors:  R Dajani; E Fraser; S M Roe; N Young; V Good; T C Dale; L H Pearl
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

Review 4.  The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

Authors:  C A Grimes; R S Jope
Journal:  Prog Neurobiol       Date:  2001-11       Impact factor: 11.685

Review 5.  GSK3 takes centre stage more than 20 years after its discovery.

Authors:  S Frame; P Cohen
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

6.  CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium.

Authors:  C A Grimes; R S Jope
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

7.  Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta.

Authors:  G N Bijur; R S Jope
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

8.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

9.  Identification of the Axin and Frat binding region of glycogen synthase kinase-3.

Authors:  Elizabeth Fraser; Neville Young; Rana Dajani; Jonathan Franca-Koh; Jonathan Ryves; Robin S B Williams; Margaret Yeo; Marie-Therese Webster; Chris Richardson; Matthew J Smalley; Laurence H Pearl; Adrian Harwood; Trevor C Dale
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

10.  A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

Authors:  Jong In Yook; Xiao-Yan Li; Ichiro Ota; Casey Hu; Hyun Sil Kim; Nam Hee Kim; So Young Cha; Joo Kyung Ryu; Yoon Jung Choi; Jin Kim; Eric R Fearon; Stephen J Weiss
Journal:  Nat Cell Biol       Date:  2006-10-29       Impact factor: 28.824

View more
  65 in total

1.  Inhibition of proprotein convertase SKI-1 blocks transcription of key extracellular matrix genes regulating osteoblastic mineralization.

Authors:  Jeff P Gorski; Nichole T Huffman; Sridar Chittur; Ronald J Midura; Claudine Black; Julie Oxford; Nabil G Seidah
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Frat is a phosphatidylinositol 3-kinase/Akt-regulated determinant of glycogen synthase kinase 3β subcellular localization in pluripotent cells.

Authors:  Matthew Bechard; Robert Trost; Amar M Singh; Stephen Dalton
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

3.  HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation.

Authors:  Gordon P Meares; Anna A Zmijewska; Richard S Jope
Journal:  Cell Signal       Date:  2007-11-17       Impact factor: 4.315

4.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

5.  GSK-3 represses growth factor-inducible genes by inhibiting NF-kappaB in quiescent cells.

Authors:  Julie R Graham; John W Tullai; Geoffrey M Cooper
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.

Authors:  Melissa Sokolosky; William H Chappell; Kristin Stadelman; Stephen L Abrams; Nicole M Davis; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2014-01-09       Impact factor: 4.534

7.  Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.

Authors:  Horacio Maldonado; Eugenio Ramírez; Elias Utreras; María E Pando; Ana M Kettlun; Mario Chiong; Ashok B Kulkarni; Lucía Collados; Javier Puente; Luis Cartier; María A Valenzuela
Journal:  J Neurosci Res       Date:  2011-06-10       Impact factor: 4.164

8.  Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.

Authors:  Braden C McFarland; G Kenneth Gray; Susan E Nozell; Suk W Hong; Etty N Benveniste
Journal:  Mol Cancer Res       Date:  2013-02-05       Impact factor: 5.852

9.  Differential responses of pancreatic β-cells to ROS and RNS.

Authors:  Gordon P Meares; Dominique Fontanilla; Katarzyna A Broniowska; Teresa Andreone; Jack R Lancaster; John A Corbett
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

10.  Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.

Authors:  Guillaume Chanoit; SungRyul Lee; Jinkun Xi; Min Zhu; Rachel A McIntosh; Robert A Mueller; Edward A Norfleet; Zhelong Xu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.